Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CY 208-243 is a selective dopamine D1 receptor agonist with anti-Parkinson disease activity.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約8-10 週間 | ¥ 176,000 |
50 mg | 約8-10 週間 | ¥ 229,000 |
100 mg | 約8-10 週間 | ¥ 358,000 |
説明 | CY 208-243 is a selective dopamine D1 receptor agonist with anti-Parkinson disease activity. |
In vivo | CY 208-243 (2.5 mg / kg; s.c.) pretreatment prevents D-1 antagonist SCH 23390 (0.05 mg / kg; s.c.)-Induced DA release and increased metabolism. |
分子量 | 274.36 |
分子式 | C19H18N2 |
CAS No. | 100999-26-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CY 208-243 100999-26-6 GPCR/G Protein Neuroscience Dopamine Receptor CY 208243 CY 208 243 Inhibitor inhibitor inhibit